Navigation Links
GSK and Valeant Receive European Authorisation for Trobalt (retigabine)
Date:3/29/2011

possible in 2011.

GlaxoSmithKline – one of the world's leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better and live longer.  For further information please visit www.gsk.com.

About Valeant PharmaceuticalsValeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

About Trobalt™(retigabine/ezogabine)Trobalt™ has been developed by Valeant and GSK as an adjunctive treatment for epilepsy patients aged 18 years and above with partial onset seizures. Retigabine is the non-proprietary name adopted by the International Non-proprietary Name for Pharmaceuticals Substances Program. In the U.S. and Canada, ezogabine is the non-proprietary name adopted by the United States Adopted Name Council. GlaxoSmithKline and Valeant entered into an exclusive worldwide collaboration agreement for Trobalt™ in 2008.

About partial onset seizures in epilepsyEpilepsy is a neurological condition that produces brief disturbances in the normal electrical signals of the brain(5). Partial seizures, which begin in a specific area in one side of the brain, are the most common type of seizure experienced by adults with epilepsy.(6)GlaxoSmithKline Enquiries:UK Media enquiries:

David Mawdsley

(020) 8047 5502Claire Brough

(020) 8047 5502Stephen Rea

(020) 8047 5502Alexandra Harrison

(020) 8047 5502Janet Morgan

(020) 8047 5502David Daley

(020) 8047 5502U.S. Media enquiries:

Nancy Pekarek

(919) 483 2839Mary Anne Rhyne


'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Valeant Pharmaceuticals Extends Contract with J. Michael Pearson as CEO and Appoints Him as Chairman of the Board
2. Valeant Pharmaceuticals Completes Acquisition of PharmaSwiss S.A.
3. Valeant Announces Pricing of Senior Notes
4. Valeant Launches Senior Notes Offering
5. Valeant Pharmaceuticals to Present at RBC Capital Markets 2011 Healthcare Conference
6. Valeant Pharmaceuticals to Announce 2010 Fourth Quarter and Full Year Results on February 24, 2011
7. Valeant Pharmaceuticals Announces License Of ACZONE® (dapsone) Gel 5% In Canada
8. Valeant Launches Senior Notes Offering
9. Valeant Pharmaceuticals to Acquire PharmaSwiss S.A.
10. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
11. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... May 01, 2015 Research and Markets ( ... Dermatology Devices Market by Type, by End User - Forecast ... Asian Dermatology Devices market is estimated to grow at a ... holds a larger share in the Dermatology devices ... . The Asian Dermatology Devices market holds a high ...
(Date:5/1/2015)... Colo. , May 1, 2015   Heska Corporation ... or the "Company"), a provider of advanced veterinary diagnostic ... Robert Grieve , Executive Chair, will present at the 16th ... (PT), on May 13, 2015. The conference will be held ... Angeles, CA. Heska management will be available during ...
(Date:5/1/2015)... 2015  CytRx Corporation (CYTR), a biopharmaceutical research ... financial results for the three months ended March ... accomplishments and upcoming milestones for its clinical development ... the early months of 2015, including the announcement ... aldoxorubicin in patients with soft tissue sarcoma, and ...
Breaking Medicine Technology:Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 2Asian Dermatology Devices (Treatment & Diagnostic) Market by Type, by End User - Forecast to 2019 3Heska to Present at the 16th Annual B. Riley & Co. Investor Conference 2CytRx Reports First Quarter 2015 Financial Results 2CytRx Reports First Quarter 2015 Financial Results 3CytRx Reports First Quarter 2015 Financial Results 4CytRx Reports First Quarter 2015 Financial Results 5CytRx Reports First Quarter 2015 Financial Results 6CytRx Reports First Quarter 2015 Financial Results 7CytRx Reports First Quarter 2015 Financial Results 8CytRx Reports First Quarter 2015 Financial Results 9CytRx Reports First Quarter 2015 Financial Results 10CytRx Reports First Quarter 2015 Financial Results 11
... , SAN DIEGO , Feb. 2 ADVENTRX ... Principal Executive Officer, Brian M. Culley , will present at the ... 2010 , at 10:30 a.m. Eastern time , in the Park ... conference is being hosted by the Biotechnology Industry Association. , Interested parties ...
... , , ... February 2 ReportsandReports announce to,have Biosimilars Series: Forecast ... The high cost and utilization of ... provides considerable momentum to,the emerging biosimilars market. With a biosimilar ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9 2ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report 2ReportsandReports: Biosimilars Series - Forecast Analysis Market Research Report 3
(Date:5/2/2015)... On Tuesday April 7th, the patient care ... celebrate improvements in patient care. In 2014 the hospital, ... zero acquired ventilator associated infections, zero central line associated ... also recently named a Top Performer by the Joint ... the teamwork of staff from all departments involved in ...
(Date:5/2/2015)... 2015 As a nonsurgical staple ... the face, neck and décolleté, radiofrequency energy is ... potential for the success of vulvovaginal rejuvenation. In ... Advisory Council, ThermiGyn’s Women’s Health Clinical Advisory Board ... that ThermiGyn’s temperature controlled radio frequency, specifically that ...
(Date:5/2/2015)... With the success that Veatch Dental Consulting has ... Neida Miranda and Alex Shields to the team. With Neida ... years of combined experience working with dentists to ensure their ... for 8 years. She was certified as dental assistant ... positive attitude and showing the importance of oral hygiene to ...
(Date:5/1/2015)... Islands, BWI (PRWEB) May 02, 2015 ... It is http://www.thevenetiangracebay.com , and it is ... incorporates the stunning white and attractive turquoise hues of ... of Google, sixty seven percent of leisure travelers used ... showed that smartphones were used in the planning and ...
(Date:5/1/2015)... Anaheim, CA (PRWEB) May 01, 2015 ... Ethos Award for the successful repositioning of its flagship ... its company brand with a new name, new logo, ... The DSA Ethos Awards are designed to identify and ... at its best. , “DSA congratulates Jusuru International ...
Breaking Medicine News(10 mins):Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 2Health News:Study Demonstrates Efficacy of Temperature Controlled Radiofrequency for Vulvovaginal Laxity 3Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:Turks and Caicos Resort, The Venetian on Grace Bay, Launches New Web Presence 2Health News:Jusuru International Receives 2015 DSA Ethos Award 2Health News:Jusuru International Receives 2015 DSA Ethos Award 3Health News:Jusuru International Receives 2015 DSA Ethos Award 4Health News:Jusuru International Receives 2015 DSA Ethos Award 5
... Reinberg HealthDay Reporter , MONDAY, Aug. 9 (HealthDay ... weight around their middle hinder the function of cells that ... pressure and other problems, a new study finds. These ... blood vessels. They control the ability of the vessel to ...
... Southwestern Medical Center has entered into an academic and ... Affiliated Hospital in Guangzhou, China. The first international institutional ... implementing the global health initiative that is one of ... developed to promote joint scientific research, educational, and training ...
... MONDAY, Aug. 9 (HealthDay News) -- Dry pet food may ... young children seem to be especially at risk, a new study ... 2006-2008 Salmonella outbreak that sickened 79 American patients -- about half ... of dry cat and dog food. "It,s a tough ...
... UCSF-led team has discovered a direct link between an ... a rare form of childhood leukemia called juvenile myelomonocytic ... link in JMML and has significant implications, the researchers ... disease. Findings are reported in the August ...
... EAST PROVIDENCE, RI A new study by researchers ... University of Puerto Rico may help explain some of ... to non-Latino white children with asthma, Latino children in ... symptoms, such as shortness of breath, when tests actually ...
... This release is available in French . ... explain how a facultative enzyme governs tumour growth A ... regulate the functions of the proteins required for cell growth ... plays a key role in developing prostate cancer. "It,s known ...
Cached Medicine News:Health News:Just a Little Belly Fat Can Damage Blood Vessels 2Health News:New partnership fosters broad scientific exchange with major Chinese university, hospital 2Health News:Your Pet's Food Dish Could Serve Up Salmonella 2Health News:Your Pet's Food Dish Could Serve Up Salmonella 3Health News:UCSF-led team discovers familial link in rare childhood leukemia 2Health News:UCSF-led team discovers familial link in rare childhood leukemia 3Health News:Latino children with asthma less accurate in determining their lung function 2Health News:Inhibiting prostate cancer without disturbing regular body processes 2
Intermittent catheter...
Intermittent catheter...
... new Finnpipette Focus from Thermo Labsystems was ... performance. Advanced features such as the ... volume adjustment on microvolumes help to define ... channel pipettes. The new interchangeable handle plate ...
Disease diagnosis and treatment reference sourced from Griffith's 5-Minute Clinical Consult. Save time diagnosing and treating more than 1,200 diseases and conditions....
Medicine Products: